mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-05 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.19 |
0.0002 |